Healthcare & Life Sciences
Resalis Therapeutics
Italy
series-a
series-a
Stage
2
Investors
About
Resalis Therapeutics develops first-in-class non-coding RNA medicines targeting obesity and metabolic diseases.
Explore Resalis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.